(GTLB) Gitlab - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US37637K1088
Stock:
Total Rating 18
Risk 48
Buy Signal -1.96
| Risk 5d forecast | |
|---|---|
| Volatility | 69.1% |
| Relative Tail Risk | -9.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.47 |
| Alpha | -80.81 |
| Character TTM | |
|---|---|
| Beta | 1.369 |
| Beta Downside | 1.131 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.03% |
| CAGR/Max DD | -0.26 |
EPS (Earnings per Share)
Revenue
Description: GTLB Gitlab
GitLab Inc., together with its subsidiaries, develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific. The company provides GitLab that covers various stages of the DevSecOps lifecycle, including project planning, source code management, integration, application security testing, packaging artifacts, delivery and deployment, infrastructure for optimal deployment, monitoring for incidents, protecting the production deployment, and managing the cycle with value stream analytics. Its platform allows customers to manage and secure their applications across various cloud through a single platform. The company also helps organizations to plan, develop, secure, and deploy software. In addition, it offers related training and professional services. The company was formerly known as GitLab B.V. and changed its name to GitLab Inc. in July 2015. GitLab Inc. was founded in 2011 and is headquartered in San Francisco, California.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -47.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 23.83 > 1.0 |
| NWC/Revenue: 103.8% < 20% (prev 102.3%; Δ 1.59% < -1%) |
| CFO/TA 0.16 > 3% & CFO 250.3m > Net Income -47.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (166.0m) vs 12m ago 1.04% < -2% |
| Gross Margin: 88.01% > 18% (prev 0.89%; Δ 8712 % > 0.5%) |
| Asset Turnover: 64.19% > 50% (prev 56.81%; Δ 7.39% > 0%) |
| Interest Coverage Ratio: -2.74 > 6 (EBITDA TTM -73.7m / Interest Expense TTM -30.9m) |
Altman Z'' -1.13
| A: 0.60 (Total Current Assets 1.51b - Total Current Liabilities 565.8m) / Total Assets 1.57b |
| B: -0.78 (Retained Earnings -1.22b / Total Assets 1.57b) |
| C: -0.06 (EBIT TTM -84.7m / Avg Total Assets 1.41b) |
| D: -2.02 (Book Value of Equity -1.22b / Total Liabilities 602.8m) |
| Altman-Z'' Score: -1.13 = CCC |
Beneish M -3.26
| DSRI: 0.88 (Receivables 221.1m/197.6m, Revenue 906.3m/711.6m) |
| GMI: 1.01 (GM 88.01% / 89.00%) |
| AQI: 0.76 (AQ_t 0.03 / AQ_t-1 0.05) |
| SGI: 1.27 (Revenue 906.3m / 711.6m) |
| TATA: -0.19 (NI -47.6m - CFO 250.3m) / TA 1.57b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of GTLB shares?
As of February 24, 2026, the stock is trading at USD 24.03 with a total of 11,387,200 shares traded.
Over the past week, the price has changed by -15.45%, over one month by -33.95%, over three months by -42.03% and over the past year by -61.42%.
Over the past week, the price has changed by -15.45%, over one month by -33.95%, over three months by -42.03% and over the past year by -61.42%.
Is GTLB a buy, sell or hold?
Gitlab has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy GTLB.
- StrongBuy: 18
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GTLB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.9 | 107.4% |
| Analysts Target Price | 49.9 | 107.4% |
GTLB Fundamental Data Overview February 21, 2026
P/E Forward = 26.5957
P/S = 5.3405
P/B = 5.393
Revenue TTM = 906.3m USD
EBIT TTM = -84.7m USD
EBITDA TTM = -73.7m USD
Long Term Debt = 392.0k USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 275.0k USD (from shortTermDebt, last fiscal year)
Debt = 392.0k USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -224.2m USD (from netDebt column, last quarter)
Enterprise Value = 3.64b USD (4.84b + Debt 392.0k - CCE 1.20b)
Interest Coverage Ratio = -2.74 (Ebit TTM -84.7m / Interest Expense TTM -30.9m)
EV/FCF = 15.01x (Enterprise Value 3.64b / FCF TTM 242.3m)
FCF Yield = 6.66% (FCF TTM 242.3m / Enterprise Value 3.64b)
FCF Margin = 26.74% (FCF TTM 242.3m / Revenue TTM 906.3m)
Net Margin = -5.25% (Net Income TTM -47.6m / Revenue TTM 906.3m)
Gross Margin = 88.01% ((Revenue TTM 906.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 86.81% (prev 87.92%)
Tobins Q-Ratio = 2.31 (Enterprise Value 3.64b / Total Assets 1.57b)
Interest Expense / Debt = 1849 % (Interest Expense 7.25m / Debt 392.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -66.9m (EBIT -84.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.66 (Total Current Assets 1.51b / Total Current Liabilities 565.8m)
Debt / Equity = 0.00 (Debt 392.0k / totalStockholderEquity, last quarter 922.7m)
Debt / EBITDA = 3.04 (negative EBITDA) (Net Debt -224.2m / EBITDA -73.7m)
Debt / FCF = -0.93 (Net Debt -224.2m / FCF TTM 242.3m)
Total Stockholder Equity = 843.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.37% (Net Income -47.6m / Total Assets 1.57b)
RoE = -5.64% (Net Income TTM -47.6m / Total Stockholder Equity 843.4m)
RoCE = -10.03% (EBIT -84.7m / Capital Employed (Equity 843.4m + L.T.Debt 392.0k))
RoIC = -7.93% (negative operating profit) (NOPAT -66.9m / Invested Capital 843.4m)
WACC = 10.96% (E(4.84b)/V(4.84b) * Re(10.96%) + (debt cost/tax rate unavailable))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.44%
[DCF Debug] Terminal Value 58.19% ; FCFF base≈242.3m ; Y1≈159.1m ; Y5≈72.6m
Fair Price DCF = 7.82 (EV 946.8m - Net Debt -224.2m = Equity 1.17b / Shares 149.8m; r=10.96% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 45.84 | EPS CAGR: 48.71% | SUE: -3.30 | # QB: 0
Revenue Correlation: 98.62 | Revenue CAGR: 35.69% | SUE: 1.98 | # QB: 2
EPS next Quarter (2026-04-30): EPS=0.20 | Chg30d=+0.000 | Revisions Net=-3 | Analysts=23
EPS next Year (2027-01-31): EPS=1.03 | Chg30d=-0.000 | Revisions Net=-3 | Growth EPS=+14.7% | Growth Revenue=+19.1%
P/S = 5.3405
P/B = 5.393
Revenue TTM = 906.3m USD
EBIT TTM = -84.7m USD
EBITDA TTM = -73.7m USD
Long Term Debt = 392.0k USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 275.0k USD (from shortTermDebt, last fiscal year)
Debt = 392.0k USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -224.2m USD (from netDebt column, last quarter)
Enterprise Value = 3.64b USD (4.84b + Debt 392.0k - CCE 1.20b)
Interest Coverage Ratio = -2.74 (Ebit TTM -84.7m / Interest Expense TTM -30.9m)
EV/FCF = 15.01x (Enterprise Value 3.64b / FCF TTM 242.3m)
FCF Yield = 6.66% (FCF TTM 242.3m / Enterprise Value 3.64b)
FCF Margin = 26.74% (FCF TTM 242.3m / Revenue TTM 906.3m)
Net Margin = -5.25% (Net Income TTM -47.6m / Revenue TTM 906.3m)
Gross Margin = 88.01% ((Revenue TTM 906.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 86.81% (prev 87.92%)
Tobins Q-Ratio = 2.31 (Enterprise Value 3.64b / Total Assets 1.57b)
Interest Expense / Debt = 1849 % (Interest Expense 7.25m / Debt 392.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -66.9m (EBIT -84.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.66 (Total Current Assets 1.51b / Total Current Liabilities 565.8m)
Debt / Equity = 0.00 (Debt 392.0k / totalStockholderEquity, last quarter 922.7m)
Debt / EBITDA = 3.04 (negative EBITDA) (Net Debt -224.2m / EBITDA -73.7m)
Debt / FCF = -0.93 (Net Debt -224.2m / FCF TTM 242.3m)
Total Stockholder Equity = 843.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.37% (Net Income -47.6m / Total Assets 1.57b)
RoE = -5.64% (Net Income TTM -47.6m / Total Stockholder Equity 843.4m)
RoCE = -10.03% (EBIT -84.7m / Capital Employed (Equity 843.4m + L.T.Debt 392.0k))
RoIC = -7.93% (negative operating profit) (NOPAT -66.9m / Invested Capital 843.4m)
WACC = 10.96% (E(4.84b)/V(4.84b) * Re(10.96%) + (debt cost/tax rate unavailable))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.44%
[DCF Debug] Terminal Value 58.19% ; FCFF base≈242.3m ; Y1≈159.1m ; Y5≈72.6m
Fair Price DCF = 7.82 (EV 946.8m - Net Debt -224.2m = Equity 1.17b / Shares 149.8m; r=10.96% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 45.84 | EPS CAGR: 48.71% | SUE: -3.30 | # QB: 0
Revenue Correlation: 98.62 | Revenue CAGR: 35.69% | SUE: 1.98 | # QB: 2
EPS next Quarter (2026-04-30): EPS=0.20 | Chg30d=+0.000 | Revisions Net=-3 | Analysts=23
EPS next Year (2027-01-31): EPS=1.03 | Chg30d=-0.000 | Revisions Net=-3 | Growth EPS=+14.7% | Growth Revenue=+19.1%